Tue, April 27, 2021

Raghuram Selvaraju Maintained (URGN) at Strong Buy with Decreased Target to $50 on, Apr 27th, 2021

Raghuram Selvaraju of HC Wainwright & Co., Maintained "UroGen Pharma Ltd." (URGN) at Strong Buy with Decreased Target from $57 to $50 on, Apr 27th, 2021.

Raghuram, nor any peers, have made any analyst calls on URGN in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30